Atlas Trials

Aravive, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Aravive, Inc.

RecordFirmDate
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced Pancreatic Adenocarcinoma (NCT04983407)Aravive, Inc.2021-07-28
Batiraxcept (AVB-S6-500)/Placebo in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer (NCT04729608)Aravive, Inc.2021-04-22
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT04300140)Aravive, Inc.2021-02-26
Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy (NCT04042623)Aravive, Inc.2019-11-27
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer (NCT03639246)Aravive, Inc.2018-12-06
A Phase 1 AVB-S6-500 Safety and Tolerability Study (NCT03401528)Aravive, Inc.2018-01-31

Track Aravive, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.